{"id":"W4321201232","doi":"10.1016/j.obmed.2023.100483","title":"Tirzepatide, a new class of incretin-based drug for diabetes","year":2023,"lang":"en","type":"article","venue":"Obesity Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration; Juvenile Diabetes Research Foundation Canada; Eli Lilly and Company","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Obesity; Weight loss; Internal medicine; Type 2 diabetes; Pediatrics; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001204105,0.0002798471,0.0003762112,0.0003762437,0.0001740648,0.0003172573,0.0002268376,0.0003006298,0.002091967],"category_scores_gemma":[0.0001629768,0.00006954604,0.0003378341,0.0002080187,0.0001452697,0.0002847934,0.0001928826,0.001283556,0.0008545996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002161431,"about_ca_system_score_gemma":0.0003182771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005496353,"about_ca_topic_score_gemma":0.002081936,"domain_scores_codex":[0.9999399,0.000007789256,0.000004701631,0.000010684,0.0000253705,0.00001161122],"domain_scores_gemma":[0.9999617,0.000006962808,0.000009278739,0.000002011237,0.000006423854,0.00001353623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002233856,0.0007657086,0.001303499,0.001427679,0.0001369976,0.001597357,0.00006788126,0.0003041119,0.1315124,0.003932118,0.03277313,0.8239453],"study_design_scores_gemma":[0.005366601,0.009354793,0.02601789,0.0005642222,0.0006505987,0.02278651,0.0001388272,0.002247093,0.06646567,0.00314138,0.8631529,0.0001134373],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2117691,0.6718372,0.01334388,0.01345928,0.003855584,0.0004092023,0.001817171,0.001534195,0.08197431],"genre_scores_gemma":[0.5225942,0.4104089,0.01913112,0.007796876,0.001642126,0.0002448456,0.001695125,0.00008357379,0.03640329],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002091967,"threshold_uncertainty_score":0.00699836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01997206219297698,"score_gpt":0.2746783828237384,"score_spread":0.2547063206307614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}